moxifloxacin has been researched along with perampanel in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (perampanel) | Trials (perampanel) | Recent Studies (post-2010) (perampanel) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 520 | 75 | 508 |
| Protein | Taxonomy | moxifloxacin (IC50) | perampanel (IC50) |
|---|---|---|---|
| Glutamate receptor 1 | Homo sapiens (human) | 1.8082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferry, J; Hussein, Z; Laurenza, A; Patten, A; Williams, B; Yang, H | 1 |
1 trial(s) available for moxifloxacin and perampanel
| Article | Year |
|---|---|
Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Electrocardiography; Epilepsies, Partial; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Nitriles; Pyridones; Reference Values; Young Adult | 2015 |